Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07184541 · ClinicalTrials.gov registry record · NA
A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care
A NA study of Heart Failure, sponsored by Lee Anne Siegmund.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT07184541: Recruiting NA study of Heart Failure, sponsored by Lee Anne Siegmund.
NCT07184541 is a NA study of Heart Failure that is actively recruiting participants, run by Lee Anne Siegmund. The registered enrollment target is 42 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07184541, a NA study of Heart Failure, is actively recruiting participants, sponsored by Lee Anne Siegmund.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool (Wake and Weigh) to affect self-care and quality of life in a population of older adults with heart failure. This will be a randomized controlled pilot trial to test the methods to be used in a larger randomized controlled trial. The Self-care in Heart Failure Index and Kansas City Cardiomyopathy Questionnaire surveys will be given at admission and four weeks after discharge. The Wake and Weigh tool is designed to help patients track weight in the hospital and following discharge. Feasibility endpoints will be summarized descriptively.
Primary Outcome
Determine intervention fidelity by examining unintended variations in intervention implementation by nurse investigators
Conditions Studied
Interventions
- BEHAVIORAL Wake and Weigh
- BEHAVIORAL Usual care
Study Locations (1)
Ohio
- Cleveland Clinic Avon Hospital - Avon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07184541 shows while recruiting
NCT07184541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Wake and Weigh is the first listed.
NCT07184541 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07184541 about?
NCT07184541 is a clinical study titled "A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care". Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool ...
What is the current status of trial NCT07184541?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2024-11-01. Estimated completion is 2026-12.
What conditions does trial NCT07184541 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT07184541?
The interventions under investigation include: Wake and Weigh (BEHAVIORAL), Usual care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07184541?
This trial is sponsored by Lee Anne Siegmund, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07184541 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07184541's enrollment target sits among peer trials
42 302nd of 397 higher than 94 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI